Growth Strategies in Pharma

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances.

The updates and advances in Pharmacovigilance regulation system are discussed in Advances in changing Pharmacovigilance regulation system track. The Pharma industry is looking to fast-growth emerging markets to fuel their growth, especially for the generics business. The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016.

  • Strategic Development towards FDA Approval
  • Post Market Product Surveillances
  • Advances in Changing Pharmacovigilance Regulation System

Related Conference of Growth Strategies in Pharma

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Growth Strategies in Pharma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in